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The transcription factor p63 is required for proper epidermal barrier formation and maintenance. Herein, we used chromatin
immunoprecipitation coupled with DNA sequencing to identify novel p63 target genes involved in normal human epidermal
keratinocyte (NHEKs) growth and differentiation. We identiﬁed over 2000 genomic sites bound by p63, of which 82 were also
transcriptionally regulatedby p63 in NHEKs. Through the discovery of interleukin-1-aas ap63 target gene, weidentiﬁedthat p63
is a regulator of epithelial–mesenchymal crosstalk. Further, three-dimensional organotypic co-cultures revealed TCF7L1,
another novel p63 target gene, as a regulator of epidermal proliferation and differentiation, providing a mechanism by which p63
maintains the proliferative potential of basal epidermal cells. The discovery of new target genes links p63 to diverse signaling
pathways required for epidermal development, including regulation of paracrine signaling to proliferative potential. Further
mechanistic insight into p63 regulation of epidermal cell growth and differentiation is provided by the identiﬁcation of a number
of novel p63 target genes in this study.
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p63, a homolog of p53, is required for proper epidermal
development.
1,2Owingtomultipletranscriptionalpromotersin
the50 endofthe gene,p63isexpressedeithercontaining (TA)
or lacking (DN) an N-terminal acidic transactivation domain.
Further, alternative C-terminal processing results in one of
three splice variants (a, b or g). Although a number of isoforms
are possible, DNp63a is the predominantly expressed isoform
in human epithelial cells.
3–5 DNp63 was originally character-
ized as having dominant-negative properties toward TAp63
isoforms and p53;
6 however, DNp63 can also positively
regulate transcription owing to an additional N-terminal
transactivation domain.
7,8
p63 /  mice display severe developmental defects, the
most notable being a complete lack of complex epithelia.
1,2
Further, these phenotypes are recapitulated in humans
bearing heterozygous germline p63 mutations.
9,10 p63
expression is localized to the basal layer of complex epithelia
andit has been speculated that p63 isrequired tomaintain the
proliferative potential of epidermal stem cells.
1,11 Additional
studies have suggested that p63 is crucial for commitment
of stem cells to an epidermal cell fate.
2 Ectopic p63
expression is sufﬁcient to induce stratiﬁcation of a single-
layered epithelium,
12 suggesting that it is a critical regulator of
epidermal differentiation.
Several approaches have been used to identify down-
stream effectors of p63, including microarray analysis,
4,5,13,14
chromatin immunoprecipitation (ChIP)-based methods,
15,16
and ChIP-on-ChIP.
17,18 Results from these studies provide
valuable insight into the mechanisms by which p63 controls
molecular signaling. However, the vast majority of studies
aimed at identifying p63-regulated signaling pathways have
used established, immortalized and tumor-derived cell lines,
all of which may not be ideally suited for understanding p63
function in normal, non-tumorigenic basal epithelium. The aim
of this study was to identify p63-regulated signaling pathways
that function in normal human epithelial cells.
Herein, we used a ChIP-based approachcoupled with gene
expression analysis of primary human epidermal keratino-
cytes (NHEKs) to identify transcriptional targets of p63. We
identiﬁed over 2000 p63-bound genes and 338 p63-regulated
genes, of which 82 genes were direct p63 target genes. By
analyzing the role(s) of select target genes in epidermis
development, we provide mechanistic insight into signaling
pathways and functions regulated by p63 during expansion
and maintenance of stratiﬁed epithelia.
Results
Identiﬁcation of genome-wide p63 binding sites. To
identify p63-bound genomic loci in rapidly proliferating
normal human basal epithelial cells, we used a ChIP-based
discovery method and primary cultures of NHEKs, as they
express robust levels of DNp63a (Figure 1a) and are able to
recapitulate epidermal differentiation in a two- and three-
dimensional culture system.
3,19 NHEKs express low levels
of a faster migrating protein that crossreacts with the
p63-speciﬁc antibody; however, it does not migrate at the
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www.nature.com/cddissame position as any p63 isoforms by SDS-PAGE and
is likely a breakdown product (ref.
3 and Figure 1a). ChIP
was performed to purify chromatin-bound p63 using the
H129 polyclonal antibody that speciﬁcally recognizes p63a
isoforms. Initial analysis revealed an enrichment of known
p63 binding sites located near the p21, MDM2, and Jagged-1
genes (Figure 1b) and validated our immunoprecipitation
conditions.
Having validated our pool of chromatin fragments, we
used GenPathway FactorPath Discovery technology to
identify novel sites bound by p63. FactorPath Discovery has
previously been used to identify genomic fragments bound
by a number of DNA-interacting proteins.
20,21 Over 5000
p63-bound chromatin fragments were isolated, sequenced,
and mapped to the human genome, with sequences mapping
within 10kb of known genes considered for further analysis.
Using these criteria resulted in 2879 p63-bound genes (see
Materials and Methods). Numerous previously identiﬁed p63
target genes were present in this dataset, including p21,
MDM2, stratiﬁn, IGFBP-3, PTPN14, RUNX1, P-cadherin,
S100A2,andclaudin-1,amongothers.Moreover,comparison
of our dataset with a previously published p63 ChIP-on-
ChIP
17 identiﬁed 874 genes (Po0.0001) common between
both datasets (Figure 1c), further validating the ability of our
assay to identify novel p63 genomic binding sites.
Discovery of novel p63 target genes in NHEKs. As
transcription factor binding to a gene does not necessitate
transcriptional regulation, we performed microarray analysis
to determine which of the identiﬁed p63 binding sites were
associated with transcriptional regulation of nearby genes.
NHEKs were transduced with a retrovirus expressing an
shRNA targeting the DNA-binding domain of p63 (p63DBD)
or GFP as a control,
4 puromycin selected, and harvested for
protein and RNA. Signiﬁcant p63 knockdown was observed
at the protein level (Figure 1d). As a threshold, we analyzed
all genes displaying a minimum of two-fold change in trans-
cript levels after p63 depletion. Using these criteria, we
identiﬁed 338 genes displaying a p63-dependent expression
pattern (Supplementary Table S1). Of these, 82 were present
in the ChIP dataset (Figure 1e) and we focused subsequent
analyses on the 82 genes (Supplementary Table S2).
Functional annotation of the 82 target genes provided
additional validation and insight into the role of p63 in
biological processes (Supplementary Table S3). ‘Cellular
movement’, one of the most signiﬁcantly enriched categories
represented by the p63 target genes, is supported by recent
data identifying p63 as a regulator of migration and the
epithelial-to-mesenchymal transition.
4,22,23 In addition, a
number of functional annotations are supported by the
phenotypeofp63 / animals,suchas‘cellulardevelopment’,
‘tissue development’, and ‘hair and skin development and
function’.
1,2 Overall, associating the 82 candidate genes with
enriched functional processes and pathways added further
conﬁdence that our approach identiﬁed valid p63 target
genes.
As a secondary screen, we performed semiquantitative
ChIPusingauniquep63antibody(4A4)thanusedtogenerate
the initial ChIP dataset (H129). For this validation, we focused
on a subset of 14 genes exhibiting a minimum of two-fold
Figure 1 Identiﬁcation of novel direct p63 target genes. (a) Rapidly growing cultures of NHEKs were analyzed for p63 isoforms by comparison with protein markers
generated by transfection of the indicated expression vectors in H1299 cells. Total protein was isolated and expression of p63 isoforms was analyzed by western blot.
(b) NHEKswere chemically crosslinkedand quantitative chromatinimmunoprecipitationused to determine therelative binding of p63 to a negativecontrol region (con) and to
three previously published p63 binding sites located in the p21, MDM2, and Jagged-1.( c) p63-bound genes in NHEKs were overlayed with p63 target genes identiﬁed in
ME180 cells.
17 Bootstrap distribution statistical analysis was performed to compare the signiﬁcance of gene overlap between the two datasets. (d) NHEKs were transduced
with a retrovirus-expressing shRNAs speciﬁc to GFP (con) or the DNA-binding domain of p63 (sip63). Cells were puromycin selected for 48h and harvested for western
analysis of p63 and actin. (e) RNA was isolated and submitted, in duplicate, for Affymetrix microarray analysis to identify genes with expression patterns dependent on the
presence of p63. Data shown are representative of at least three independent experiments. p63-bound genes identiﬁed in the ChIP dataset (left circle) were overlayed with
genesexhibitingp63-dependentexpressioninmicroarrayanalyses(rightcircle).Eighty-twogenes,asannotatedbytheGeneSpring7software,werepresentinbothdatasets
and were chosen for further biological analyses
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Cell Death and Diseaseregulation by p63, and that we could link to epidermal biology
through previous publications. The known p63 binding site
located in the p21 promoter and an exon sequence located
in the GAPDH gene were used as positive and negative
controls, respectively. Statistically signiﬁcant p63 binding
to promoter or intronic sequences was observed for 11 of
the 14 genes analyzed (Figure 2).
In secondary analyses to conﬁrm p63-dependent trans-
criptional regulation of select target genes, NHEKs were
transduced with siRNA-expressing adenovirus targeting the
p63DBD, or shuttle adenovirus as a control.
5 This knockdown
strategy is unique from the retrovirus used to generate initial
microarray datasets. After successful p63 depletion at the
protein level (Figure 3a), qPCR analyses revealed that all
target genes analyzed displayed p63-regulated transcript
changesthat were consistent with those observed in our initial
microarray observations (Figure 3b), validating these genes
as bona ﬁde p63-regulated genes.
Despite its low, often undetectable protein levels, recent
evidence suggests that endogenous TAp63 isoforms can
regulate target gene expression and differentiation of primary
epithelial cells.
19,24 As our siRNAs target all p63 isoforms, we
designed independent siRNAs that speciﬁcally target TAp63
and tested the efﬁcacy of each against exogenous TAp63g in
H1299 cells, which lack detectable expression of any p53
family members. We observed a robust knockdown of
TAp63g at the protein level (Figure 3c). Further, we conﬁrmed
that these siRNAs do not target TAp73b (Figure 3d), or endo-
genous p53 and DNp63 isoforms (Figure 3e). To test the
dependency of target gene expression on TAp63, we
transfected non-silencing (NS) or TAp63-speciﬁc siRNAs into
NHEKs to deplete endogenous TAp63 levels. Speciﬁc knock-
down of endogenous TAp63, but not DNp63, isoforms was
conﬁrmed by qPCR (Figure 3f). At 48lh after transfection,
target gene expression was determined and compared
with those changes observed after depleting all p63 isoforms
(compare 3G to 3B). Although all analyzed genes were
dependent on DNp63 isoforms for expression, consistent
with DNp63a being the predominant isoform expressed in
epithelial cells, few, if any, genes showed a signiﬁcant
dependence on TAp63 for expression. Taken collectively,
these data suggest that, of the target genes analyzed, DNp63
isoforms function as the primary regulator of transcriptional
regulation.
p63 target genes correlate with p63 expression in
squamous cell carcinoma. Consistent with the role of
p63 in maintaining proliferative potential in normal basal
epithelium,
1 ampliﬁcation of its genomic locus is observed in
squamous cell carcinomas,
25 particularly those derived from
tissues of the head and neck (HNSCC). To analyze the
expression of our novel p63 target genes versus p63 in
an in vivo setting, we used two publicly available HNSCC
gene expression datasets.
26,27 We used the gene expres-
sion proﬁles of tumors exhibiting high versus low p63
expression (Supplementary Figure S1A) and compared the
expression of our target genes between each subset. Of the
82 novel p63 targets, 25 genes exhibited differential
expression patterns in HNSCC, when clustered for p63
expression (Supplementary Figure S1B). Of note, many
p63 target genes were not differentially expressed in these
datasets. We speculate that the latter is owing to differential
expression of p53, p73, or other co-factors between normal
and tumor cells, or the relative contribution of TAp63 versus
DNp63 expression, which was not possible to assess from
the tumor microarray expression data. Nevertheless, the
correlation between 25 target genes and p63 status in an
in vivo setting further supports our ﬁndings that these target
genes contribute to p63-mediated biological processes in
both normal and tumorigenic settings. Given this
observation, we chose to functionally analyze two of these
genes and determine the mechanism by which they
contribute to p63-regulated biological processes.
p63 regulates paracrine signaling between epidermal
keratinocytes and dermal ﬁbroblasts. Interleukin-1-a
(IL1A) is a secreted factor important for maintaining
epidermal homeostasis by regulating ﬁbroblast-derived
Figure 2 Validation of p63-bound response elements located in/near target genes. Rapidly growing NHEKs were chemically crosslinked, snap frozen, and submitted for
FactorPathquery analysis. Speciﬁc p63 binding sites were selected from the regions identiﬁed by the initial ChIP experiment. A majority of the sites queried were enriched by
p63 immunoprecipitation, with statistically signiﬁcant hits marked with an asterisk (*Po0.05; **Po0.01). Data presented were generated from three independent
experiments. Please note that for BDKRB2, we identiﬁed two independent p63 binding sites, denoted (1) and (2)
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Cell Death and Diseasecytokines.
28 Expressed in basal keratinocytes, IL1A is
secreted to dermal ﬁbroblasts where it induces the
expression of ﬁbroblast-derived growth factors, such as
KGF, GM-CSF, and FGF10.
29 These factors, in return,
induce both the proliferation and differentiation of epidermal
keratinocytes, thus completing an essential paracrine loop
(Figure 4a).
30,31
The identiﬁcation of IL1A as a p63 target gene in
keratinocytes led us to hypothesize that p63 regulation of
secreted cytokines is important for paracrine control of
ﬁbroblast-derived cytokines that are essential for proper
development and maintenance of the epidermis. Consistent
with this hypothesis, siRNA-mediated depletion of p63 in
NHEKs (Figure 4b) resulted in signiﬁcantly lower levels of
secreted IL1A, as measured by ELISA (Figure 4c). To
determine whether NHEKs could induce ﬁbroblast-derived
cytokine expression in a paracrine manner, we cultured
dermal ﬁbroblasts (NHDFs) in media conditioned by NHEKs.
After NHDF growth in NHEK-conditioned medium for 48h, we
observed a signiﬁcant induction of the ﬁbroblast-derived
growth factors, KGF, FGF10, and GM-CSF, relative to
unconditioned keratinocyte media (Figures 4d and e). To test
our hypothesis that p63 regulates, in a paracrine manner, the
expression of ﬁbroblast-speciﬁc cytokines, we transfected
NHEKs with control, p63, or IL1A-speciﬁc siRNA, and
collected conditioned media from the cultures. IL1A depletion
was veriﬁed by qPCR analysis in NHEKs (Figure 4f). NHDFs
culturedinthemediumconditionedbyNHEKsdepletedofp63
had signiﬁcantly reduced the production of KGF, FGF10, and
GM-CSF, relative to control cells (Figures 4g–i), suggesting
that p63 signaling in keratinocytes is important for promoting
epidermis–dermis paracrine signaling. Of note, these data
were not a result of overall decrease in NHEK cell number
following p63 knockdown, as we observed minimal cell death
Figure 3 Validation of genes displayinga p63-dependentexpressionpattern.(a)NHEKs weretransduced with adenovirus-expressing p63DBD siRNA,or shuttle virus as
a control. Protein lysates were harvested 48h later and western blot analysis performed for p63 and actin. (b) Rapidly growing NHEKs were treated as in (a) and RNA was
isolated 48h after infection and target genes analyzed by quantitative real-time PCR. Data presented are representative of three independent experiments. (c) Three TAp63-
speciﬁc siRNAs were co-transfected with TAp63g into H1299 cells. The expression of TAp63 was analyzed as in (a). (d) TAp63 siRNAs were co-transfected with TAp73b.
p73-speciﬁc siRNAs were used as a positive control for knockdown. Expression of TAp73 and actin were analyzed as in (a). (e) TAp63 siRNAs were transfected into NHEKs
and levels of DNp63a, p53, and actin were analyzed by western blot. (f) NHEKs were transfected with TAp63-speciﬁc siRNAs and qPCR was used to analyze endogenous
levels of DNp63 and TAp63 transcript levels 48h after transfection. (g) NHEKs were transfected with NS, or TAp63-speciﬁc siRNAs as in (b), and RNA was analyzed by
quantitativereal-timePCRtoobservetranscriptlevelsofasubsetofnoveldirectp63targetgenes.EachofthethreesiTAp63oligosweretransfectedintoindependentcultures
of NHEKs, and data presented next to the original microarray data (gray bar) represent the mean of all three TAp63 siRNA experiments (black bar)
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Cell Death and DiseaseFigure 4 p63 regulates paracrine pathways between keratinocytes and dermal ﬁbroblasts. (a) Model of paracrine signaling between the epidermis and the dermis.
(b) NHEKs were transiently transfected with control (NS) or p63-speciﬁc siRNA, harvested 72h later, and p63 and actin protein levels analyzed by western blot.
(c) Conditioned medium from transfected NHEKs was collected 72h after transfection and secreted IL1A concentration was determined by ELISA. (d) NHEK-conditioned
medium (cm) was obtained by growing NHEKs for 48h, ﬁltered, and given as the only media to NHDFs for 24h. Unconditioned NHEK medium (ucm) was used as a control.
NHDFs were harvested 24h after the addition of medium and harvested for RNA. Quantitative real-time PCR was used to quantify the expression of the ﬁbroblast-speciﬁc
growth factors KGF and FGF10 in response to NHEK-conditioned medium, relative to an unconditioned control. (e) NHDFs were treated as in (d) and GM-CSF levels were
analyzed and graphed independently owing to the robust induction observed following cm addition. (f) NHEKs were transfected with NS or IL1A-speciﬁc siRNA and IL1A
depletionwasconﬁrmedbyqPCR48haftertransfection.(g)NHEKsweretransfectedwithp63orIL1AsiRNAaloneorincombination,aswellasnon-silencingsiRNA(NS)as
a control. At 48h after transfection, the media were replaced, conditioned medium was generated, and NHDFs were treated as in (d). KGF expression was measured
by qPCR 24h after the addition of conditioned medium. (h) NHDFs treated as in (g) and qPCR was used to analyze the expression of GM-CSF or FGF10 (i). (j) NHEKs
were transduced with shuttle (sicon) or p63 siRNA- (sip63) expressing adenovirus. Cells were harvested, RNA isolated, and quantitative real-time PCR performed to analyze
the expression of p63 and KGFR. All quantitative PCR data were normalized to actin levels and error bars represent standard deviation of at least three independent
experiments. *Po0.5
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Cell Death and Diseaseand detachment following transfection (data not shown).
Interestingly, we observed a similar, slightly less robust,
inhibition of cytokine production using the conditioned
medium from NHEKs expressing reduced levels of IL1A
(Figures 4g–i). We were not able to further inhibit cytokine
productionbydepleting p63andIL1Aconcomitantly,suggest-
ing that the majority of paracrine signaling controlled by p63 is
owing to its regulation of IL1A expression.
Of these ﬁbroblast-derived cytokines, KGF binds to its
cognate keratinocyte receptor, KGFR, on basal epidermal
cell, and it acts as a potent mitogen to induce pro-
liferation of epidermal progenitor cells. We hypothesized
that p63 may also regulate the expression of KGFR in
basal epidermal cells. Indeed, the expression of KGFR was
signiﬁcantly reduced after p63 knockdown (Figure 4j), sug-
gesting that p63 acts to regulate KGFR expression in basal
keratinocytes. Collectively, through the identiﬁcation of IL1A
as a p63 target gene, we discovered a role for p63 in
regulating paracrine signaling pathways between epidermal
keratinocytes and dermal ﬁbroblasts.
TCF7L1 regulates a proliferation–differentiation switch
in three-dimensional organotypic cultures. TCF7L1 is a
downstream component of the Wnt signaling pathway. It acts
as an effector to control the transcriptional state of Wnt-
regulated target genes. Recent data suggest that TCF7L1
can control cell fate lineage commitment in multipotent skin
stem cells.
32 In addition, induction of TCF7L1 in mouse
epidermal progenitor cells is sufﬁcient to abrogate terminal
differentiation and maintain an undifferentiated cell fate.
33
We analyzed TCF7L1 expression during calcium-induced
NHEK differentiation in monolayer. Consistent with p63
expression, TCF7L1 levels correlated with the undifferentiated
state of keratinocytes and signiﬁcantly decreased as cells
underwent terminal differentiation (Figures 5a and c, control
lanes). From these data, we hypothesized that TCF7L1 is
important for maintaining the undifferentiated state of
p63-expressing, rapidly growing NHEKs. To test this hypo-
thesis,weusedcontrolorTCF7L1-overexpressingNHEKsand
induced terminal differentiation in culture. Ectopic TCF7L1
expression decreased mRNA levels of ﬁlaggrin, loricrin, and
involucrin (Figure 5b), substantially reduced the protein levels
of loricrin and crosslinked involucrin (Figure 5c), and thus
attenuated differentiation. In both settings, calcium-induced
differentiation decreased DNp63a levels by 6 days, providing
additional evidence that TCF7L1 functions downstream of p63
(Figure 5c). These data further supported our hypothesis that
TCF7L1 is crucial for maintaining a rapidly growing, undiffer-
entiated state of p63-expressing keratinocytes.
To determine the function of endogenous TCF7L1 in
NHEKs, we used a three-dimensional organotypic co-culture
(OTC) model system to analyze differentiation in control
Figure 5 TCF7L1 is a negative regulator of keratinocyte differentiation. (a) At conﬂuency, rapidly growing monolayers of NHEKs were treated with 1.4mM calcium to
induce differentiation. Cultures were harvested at the indicated time points, RNA isolated, and qRT-PCR performed to determine the expression of p63 and TCF7L1 during
differentiation. Expression levels were normalized to actin levels and presented relative to cultures at day 0. Error bars represent standard deviation of three replicate
experiments. (b) NHEKs were transduced with control or ectopic TCF7L1-expressing lentivirus and induced to differentiate 48h after infection. Cultures were collected at
indicated time points and RNA was isolated for qPCR analysis of differentiation genes. Error bars represent standard deviation of three independent experiments. (c) NHEKs
were treated as in (b), protein harvested at indicated time points, and levels of TCF7L1, p63, involucrin, loricrin, and actin analyzed by western blot
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Cell Death and DiseaseNHEKs as compared with TCF7L1-deﬁcient NHEKs. Like
cultured NHEKs grown in the monolayer, the predominant
isoform of p63 expressed in epidermal portion of OTCs
is DNp63a (Supplementary Figure S2). To modulate
endogenous TCF7L1 levels, we transfected NHEKs with
TCF7L1-speciﬁc siRNAs, as well as with NS siRNAs to serve
as a control. Although signiﬁcant TCF7L1 depletion was
achieved, endogenous p63 protein levels were not altered
Figure 6 Loss of TCF7L1 results in early differentiation of NHEKs in OTC. (a) NHEKs were transfected with siRNAs targeting TCF7L1 or non-silencing oligos (NS) as a
control. At 48h after transfection, RNA was isolated and qRT-PCR performed to assess the expression of TCF7L1. (b) Immunoﬂuorescent analysis of control and siTCF7L1
OTCs were performed with antibodies speciﬁc for ﬁlaggrin, involucrin, loricrin, keratin 2, and E-cadherin. Dotted line represents the epidermis–dermis interface. For
proliferation analysis, OTCs were grown in medium containing BrdU for 16h before harvesting in order to label proliferative cells. Immunoﬂuorescence with a BrdU-speciﬁc
antibody was performed to identify actively proliferating cells in the epidermal layers of OTCs. (c) BrdU-positive cells from (b) were quantiﬁed and graphed. Data shown are
representative of three independent experiments
p63 targets regulate epidermal biology
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Cell Death and Disease(Figure 6a). At 24h after transfection, NHEKs were plated
ontogelscomposedofrat-tailcollagenembeddedwithnormal
human dermal ﬁbroblasts and lifted to the air–liquid interface.
After 10 days, cultures were harvested and in situ expression
of various proteins analyzed by immunoﬂuorescence. In
control cultures, involucrin expression was detected in the
upper spinous layers, whereas ﬁlaggrin, loricrin, and keratin 2
were largely restricted to the stratum granulosum (Figure 6b).
In TCF7L1-depleted cultures, we observed an earlier onset of
all observed differentiation markers, with involucrin being
present throughout all suprabasal layers. Furthermore,
ﬁlaggrin, loricrin, and keratin 2, typically restricted to the
stratum granulosum, were already detectable in spinous
layers of the epidermis (Figure 6b). We did not observe
measurable differences in the cell–cell contact protein
E-cadherin, suggesting that the effects of TCF7L1 depletion
is limited to proteins involved in terminal differentiation. These
data suggest that keratinocytes, when depleted of TCF7L1
expression, prematurely initiate a program of terminal
differentiation in OTC.
We hypothesized that following TCF7L1 depletion, increa-
sed differentiation would be accompanied by decreased
proliferation. As seen in Figures 6b and c, there was a
signiﬁcant decrease in the number of 5-bromodeoxyuridine
(BrdU)-positive cells in siTCF7L1 cultures compared with
control cultures. Coupled with our ectopic TCF7L1 data, our
studies suggest that TCF7L1-depleted keratinocytes are
unable to maintain an undifferentiated state. Moreover, we
identiﬁed a number of Wnt target genes that displayed
signiﬁcant expression changes following p63 depletion in
NHEKs (Supplementary Figure S3), consistent with the
transcriptional regulatory function of TCF7L1. Our combined
use of a genomic approach to identify new target genes, and
an organotypic assay to screen for functions downstream of
p63, allowed us to mechanistically link p63 signaling to a
critical proliferation/differentiation switch (TCF7L1) in strati-
ﬁed epithelia.
Further identiﬁcation of novel p63 target genes in
NHEKs. A recent study by Truong et al.
19 reported that
231 genes were regulated in a p63-dependent manner in
NHEKs grown in an organotypic culture. However, the
experimental design did not reveal which of these genes
were direct targets of p63 regulation. By overlaying our ChIP
dataset with the microarray dataset from this previous study,
we identiﬁed 32 additional genes as directly regulated by p63
in primary keratinocytes (Table 1). Thus, we were able to
extend the use of our ChIP dataset outside this study to
further identify novel p63 target genes using publicly
available expression datasets.
Discussion
In this study, we used a ChIP-based methodology, coupled
with expression microarray, to identify p63 binding sites in
NHEKs. Although previous studies have used ChIP-based
approaches to identify p63-bound genomic regions in
numerous epithelial models,
16 ours is the ﬁrst study in primary
human keratinocytes. We discovered 874 genes (Po0.0001)
in common between our ChIP dataset and a previously
published ChIP-on-ChIP dataset.
17 Despite signiﬁcant over-
lap, the large number of genes unique to p63 regulation in
NHEKs, versus the transformed ME180 cell line, suggests
that there are signiﬁcant differences between p63 signaling in
normal keratinocytes as compared with immortalized and/or
tumorigenic settings.
Coupling ChIP-based data with microarray analyses
allowed for rapid identiﬁcation of 82 p63 target genes in
Table 1 p63 target genes present in this study
a and Truong et al.
b dataset
Pubmed
ID
Gene
symbol
Gene name
54 ACP5 Acid phosphatase 5
10962 AF1Q Myeloid/lymphoid or mixed-lineage
leukemia
196 AHR Aryl hydrocarbon receptor
57016 AKR1B10 Aldo–keto reductase family 1,
member B10
217 ALDH2 Aldehyde dehydrogenase 2
397 ARHGDIB Rho GDP dissociation inhibitor, beta
9048 ARTN Artemin
8424 BBOX1 Butyrobetaine, 2-osoglutarate
dioxygenase 1
51806 CALML5 Calmodulin-like 5
8824 CES2 Carboxylesterase 2
9076 CLDN1 Claudin-1
9022 CLIC3 Chloride intracellular channel 3
9547 CXCL14 Chemokine (C–X–C motif) ligand 14
1605 DAG1 Dystroglycan 1
1849 DUSP7 Dual speciﬁcity phosphatase 7
1999 ELF3 E74-like factor 3
8507 ENC1 Ectodermal-neural cortex
(with BTB-like domain)
2355 FOSL2 FOS-like antigen 2
2537 G1P3 Interferon, alpha-inducible protein 6
2752 GLUL Glutamate-ammonia ligase
2760 GM2A GM2 ganglioside activator
3162 HMOX1 Heme oxygenase (decycling) 1
3486 IGFBP3 Insulin-growth factor binding protein 3
3552 IL1A Interleukin 1 alpha
182 JAG1 Jagged-1
5655 KLK10 Kallikrein-related peptidase 10
11012 KLK11 Kallikrein-related peptidase 11
8942 KYNU Kynureninase
1241 LTB4R Leukotriene B4 receptor
4053 LTBP2 Latenttransforminggrowthfactorbeta
binding protein 2
4059 LU Basal cell adhesion molecule
4199 ME1 Malic enzyme 1
9788 MTSS1 Metastasis suppressor 1
4580 MTX1 Metaxin 1
26031 OSBPL3 Oxysterol binding protein-like 3
22822 PHLDA1 Pleckstrin homology-like domain,
family A, member 1
5317 PKP1 Plakophilin 1
23682 RAB38 RAB38, member RAS oncogene
family
50862 RNF141 Ring-ﬁnger protein 141
6236 RRAD Ras-related associated with diabetes
861 RUNX1 Runt-related transcription factor 1
5054 SERPINE1 Serpin peptidase inhibitor, clade E,
member 1
6513 SLC2A1 Solute carrier family 2
26027 THEA Acyl-CoA thioesterase 11
8795 TNFRSF10B Tumor necrosis factor receptor
superfamily, member 10B
203068 TUBB Tubulin, beta
22695 ZFP36 Zinc-ﬁnger protein 36
Genes in bold were identiﬁed in this study as p63 target genes.
aThese genes
represent the overlap between our ChlP dataset and all NHEK microarray
dataset in Truong et al.
19 bTroung et al.
19
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Cell Death and DiseaseNHEKs, andsecondaryvalidation ofour datasets werecrucial
in ruling out false-positive genes. This validation included
the use of a second p63 antibody to conﬁrm the ChIP results,
along with the use of a unique p63-speciﬁc siRNA to
corroborate the microarray expression dataset. Furthermore,
we identiﬁed in vivo correlations between the expression of
p63 and direct target genes in HNSCC, suggesting that these
genes are important for mediating the function of p63 in a
tumorigenic environment. We are currently working to identify
the role(s) of these genes in a tumorigenic setting, and these
studies will provide insight into how p63 functions in both
normal and tumor-derived epithelia.
Expressed in basal, proliferating, keratinocytes, IL1A is
required for the induction of ﬁbroblast-speciﬁc cytokines
involved in paracrine signaling between the epidermis and
the dermis.
28 We discovered that keratinocyte-speciﬁc p63
expression is important for the induction of ﬁbroblast-derived
cytokines. Further, p63 regulates the keratinocyte-speciﬁc
KGFR, a trans-membrane receptor that binds ﬁbroblast-
derived KGF. Our data are consistent with a previous report
linking p63 and KGFR in thymic epithelial cells.
34 Most
importantly, our data show that p63 is important for regulating
targetgeneexpressionintheepidermis,andtheexpressionof
ﬁbroblast-speciﬁc growth factors that promote epidermis
development in a paracrine manner. Although our data
suggest that p63 regulates paracrine signaling primarily
through IL1A production, we cannot rule out the possibility
that p63 also regulates the expression of additional secreted
factors that function in epithelial–mesenchymal paracrine
pathways.
Psoriasis, an epidermal disorder characterized by hyper-
proliferation, hypodifferentiation, and increased p63 expres-
sion,
35 further links p63 to paracrine pathways mediated by
IL1A. Consistent with our discovery of IL1A being induced by
p63, previous studies identiﬁed increased expression of KGF
and FGF10 in the stroma adjacent to psoriatic lesions.
36 On
thebasisofourdata,wewouldhypothesizethattheincreased
stromal levels of KGF and FGF10 are a direct result of IL1A
induction by p63, which is upregulated during psoriatic
remodeling.
35
We showed that TCF7L1 functions to maintain the
undifferentiated state of basal keratinocytes. Ectopically
expressed TCF7L1 was sufﬁcient to abrogate calcium-
induced NHEK differentiation. In OTC, TCF7L1 depletion
was sufﬁcient to prematurely induce differentiation, suggest-
ing that it acts to repress differentiation pathways in human
keratinocytes and thus have an important role in tissue
homeostasis. These data are consistent with previous studies
showingthatectopicTCF3,themouseTCF7L1homolog, was
sufﬁcient to induce an undifferentiated, proliferative state in
mouse keratinocytes.
33 There is additional evidence from
Xenopus studies that link p63 to TCF7L1. In Xenopus,
xTcf3 /  embryos display severely expanded mesodermally
derived structures, suggesting that it may act to repress
transcriptional programs responsible for mesoderm differen-
tiation.
37 We recently identiﬁed a role for DNp63 as
a repressor of mesoderm development during Xenopus
embryogenesis.
38 Further researchisnecessary todetermine
whether DNp63 transcriptionally regulates xTcf3 during
Xenopus development. Given that previous reports describe
p63 as a regulator of proliferation and differentiation in basal
epithelial cells,
1 our linkage of p63 to TCF7L1 expression in
basal epithelial cells provides mechanistic insight into how
p63 regulates the maintenance of epithelial progenitor cells.
Lastly,ourChIPdatasetprovedusefultofurtheridentifyp63
target genes in a previously published study.
19 Overlaying our
ChIP dataset with microarray data from their study identiﬁed
32 additional p63 target genes not present in this study, such
as claudin-1, Jagged-1, and RUNX1, all known p63 target
genes, as well as keratinocyte differentiation genes, such as
SERPINE1 and PKP1. Ultimately, our ChIP dataset, used in
conjunction with microarray analyses, will provide a tiered
panel to identify direct versus indirect regulation of target
genes by p63 in gene expression analyses.
In conclusion, we show that p63 acts to regulate both cell
autonomous and non-autonomous pathways involved in
keratinocyte growth and differentiation. Our study provides
numerous novel p63target genes thatwill be ofvalue tofuture
investigation of transcriptional networks involved in complex
epithelia development and differentiated function.
Materials and Methods
Cell culture. Primary NHEKs were obtained and cultured as described
previously.
3 Primary human dermal ﬁbroblasts were obtained from the Vanderbilt
Skin Disease Research core and cultured in Dulbecco’s minimal Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum and 1% penicillin–
streptomycin. The retrovirus-packaging cell line, Phoenix, was cultured in DMEM
supplementedwith10%fetalbovineserumand1% penicillin–streptomycin.Allcells
were cultured at 371C with 5% CO2. Terminal differentiation of NHEKs was
performed as described previously.
3
Protein lysate preparation and western blot analysis. Protein
lysateswerepreparedfromNHEKsasdescribedpreviously.
3Westernanalysiswas
performed as described previously
3 with the following primary antibodies: anti-p63
monoclonal antibody 4A4 (Santa Cruz, Santa Cruz, CA, USA), anti-p73 A300
(Bethyl, Montgomery, TX, USA), anti-p53 clone DO-1 (Santa Cruz), anti-TCF7L1
(Santa Cruz), loricrin (Covance, Princeton, NJ, USA), involucrin, and b-actin
polyclonal antibody I-19 (Santa Cruz).
Quantitative reverse transcription-PCR. Quantitative reverse
transcription-PCR (RT-PCR) and 13 real-time PCR were performed as described
previously.
4,13 Primer sequences and PCR conditions are available upon request.
ChIPexperiments. Formaldehydecrosslinkingandchromatinpreparationand
ChIP were carried out as described previously.
15 For ChIP data generation and
semiquantitative ChIP PCR experiments, rapidly growing NHEKs were crosslinked
and submitted to GenPathway Inc. (San Diego, CA, USA) according to their
FactorPath protocol. The complete p63 ChIP dataset is accessible through Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/).
Microarray analyses. siRNA-mediated disruption of p63 for microarray data
generation was performed using the pRetroSuper system as described in ref.
4 RNA
was harvested and Affymetrix microarray analysis was performed in duplicate as
described previously.
4 All gene expression data from microarray experiments and
genomiclocationinformationfromthep63ChIPexperimenthavebeendepositedin
the National Center for Biotechnology Information GEO (http://www.ncbi.nlm.nih.
gov/geo/). The GeneSpring GX software (Agilent, Santa Clara, CA, USA) was used
for statistical analyses and transcript annotations. For tumor analysis, publicly
available expression data from GSE3524 and GSE2280 were pooled and used to
identify tumors with high and low p63 mRNA expression, as measured by mRNA
levels. The 82-gene p63 signature was analyzed in these two tumor subgroups to
identify genes differentially regulated in tumors relative to p63 expression.
siRNA experiments and immunoﬂuorescence. For validation studies,
p63 was depleted using adenoviruses expressing siRNAs targeting the p63DBD or
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Cell Death and Diseasea shuttle control virus as described previously.
5 For TA-speciﬁc knockdown
experiments, TAp63 was depleted using the following siRNA oligonucleotides:
siTAp63-1, 50-CAGAAGATGGTGCGACAAA-30; siTAP63-2, 50-GCACACAGAC
AAATGAATT-30; and siTAp63-3, 50-ACTTGAACTTTGTGGATGA-30. For TCF7L1
knockdown studies, siRNA (Dharmacon Inc., Lafayette, CO, USA) was
electroporated into primary NHEKs as per the manufacturer’s instructions
(Amaxa Biosystems, Walkersville, MD, USA). For immunoﬂuorescence, sections
were processed as described previously.
39 After primary incubation, sections were
incubated with the appropriate secondary antibody (AlexaFluor 488 or 546)
(Molecular Probes and Invitrogen, Carlsbad, CA, USA). Nuclei were stained using
TOPRO-3 (Invitrogen). Sections were analyzed on a Zeiss Inverted LSM510
confocal microscope (Vanderbilt-Ingram Cancer Center Cell Imaging Shared
Resource, Nashville, TN, USA). Primary antibodies used were as follows: loricrin
(Covance, Princeton, NJ, USA), involucrin, and ﬁlaggrin (Santa Cruz), and
E-cadherin (BD Biosciences, Franklin Lake, NJ, USA). For proliferation analyses,
theOTCswereincubatedwithamixtureofBrdUand5-bromodeoxycytidine(Sigma,
St Louis, MO, USA; both 63.5mM, added to the culture medium) for 18h before
being terminated. DNA incorporation of these nucleotide analogs in replicating cells
was detected on cryosections with a monoclonal antibody anti-BrdU antibody
(BD Biosciences) after sequential methanol and acetone ﬁxation as described
above and 10min incubation with 1.5M HCl at room temperature followed by
thoroughrinsinginPBS.Todeterminetheproliferativeindices,BrdU-labeledandall
basalcellnucleiwerecountedinatleastthreevisionﬁeldsofthreetoﬁvesectionsof
each culture specimen.
Organotypic co-culture. OTCs were prepared as described previously.
40
Type I collagen was purchased from BD Biosciences. The gels, containing primary
ﬁbroblasts and representing the dermal equivalents, were incubated in DMEM
supplemented with 10% fetal bovine serum and 50mg ascorbic acid per ml. Culture
medium was changed every 2 days and cultures were harvested for analysis
10 days after lift.
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